M&A Activity in 2021 Ends with a Bang
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 1 (Table of Contents)
Published: 17 Jan-2022
DOI: 10.3833/pdr.v2022.i1.2655 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
With the COVID-19 pandemic having a profound effect on deal activity in 2020, 2021 saw the life sciences sector returning to the deal making agenda, as companies attempted to scale up and diversify their portfolios...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS